Moon Surgical announced it received FDA clearance for ScoPilot, a Nvidia-enabled platform for its Maestro surgical robot. The Paris-based company also announced further integrations with Nvidia technologies, including the Isaac for Healthcare platform.
ScoPilot, enabled by Nvidia Holoscan, is a real-time sensing platform designed to develop and deploy applications based on AI in the OR. It runs locally on Moon Surgical’s Maestro system, making it the first AI application to run intraoperatively on any commercially available surgical robotic platform with Holoscan, according to a news release.
Related: FDA clears robotic knee surgery system from Monogram Technologies
Moon Surgical said ScoPilot enables a stable and ideal view during surgery. It aims to enhance control, safety and efficiency in the OR. The company describes ScoPilot as on-demand and easy to use, allowing a laparoscope attached to Maestro to follow a desired instrument tip seamlessly. The surgeon controls laparoscope positioning without disengaging the instrument from their hands. That helps maintain surgical flow and focus.
The company designed Maestro to provide an accessible, enhanced version of traditional laparoscopy. Maestro acts as a robotic surgical assistant to augment the precision and control of laparoscopic surgery. The small, adaptable system can integrate into existing clinical workflows. It features capabilities that bolster operating room efficiency and allow for alternative labor models.
“ScoPilot empowers surgeons to control three instruments with just two hands, while offering a stable, constantly optimal, and safe field of view that is crucial during surgery,” said Anne Osdoit, CEO of Moon Surgical. “The control provided by Maestro’s ScoPilot will enhance OR efficiency by making the surgeon more autonomous while improving procedural visualization.”
